EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Obesity and the gut microbiota: implications of neuroendocrine and immune signaling

Marina Romaní-Pérez, Rebeca Líebana-García, Alejandra Flor-Duro, Daniel Bonillo-Jiménez, Clara Bullich-Vilarrubias, Marta Olivares, Yolanda Sanz iD

The FEBS Journal · 2025

DOI: 10.1111/febs.17249 ↗

At a glance

Übersichtsarbeit in The FEBS Journal, 2025. Written by Marina Romaní-Pérez and 6 co-authors. Institution: Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain. Major MEDLINE topics: Gastrointestinal Microbiome, Obesity, Neurosecretory Systems. Cited 32 times so far (Crossref); 181 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The European Commission - NextGeneration EU, Spanish Ministry of Science and Innovation, Ministerio de Ciencia e Innovación.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Obesity is a major health challenge due to its high prevalence and associated comorbidities. The excessive intake of a diet rich in fat and sugars leads to a persistent imbalance between energy intake and energy expenditure, which increases adiposity. Here, we provide an update on relevant diet–microbe–host interactions contributing to or protecting from obesity. In particular, we focus on how unhealthy diets shape the gut microbiota and thus impact crucial intestinal neuroendocrine and immune system functions. We describe how these interactions promote dysfunction in gut‐to‐brain neuroendocrine pathways involved in food intake control and postprandial metabolism and elevate the intestinal proinflammatory tone, promoting obesity and metabolic complications. In addition, we provide examples of how this knowledge may inspire microbiome‐based interventions, such as fecal microbiota transplants, probiotics, and biotherapeutics, to effectively combat obesity‐related disorders. We also discuss the current limitations and gaps in knowledge of gut microbiota research in obesity.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal MicrobiomeObesityNeurosecretory SystemsHumansAnimalsSignal TransductionEnergy Metabolism

Author keywords

dietenteroendocrine hormonesgut microbiotainflammationobesity

Authors and institutions

  • Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain.

ORCID profiles: Yolanda Sanz

Funding

  • The European Commission - NextGeneration EU
  • Spanish Ministry of Science and Innovation
  • Ministerio de Ciencia e Innovación

Cite

APA

Romaní-Pérez, M., Líebana-García, R., Flor-Duro, A., Bonillo-Jiménez, D., Bullich-Vilarrubias, C., Olivares, M., & Sanz, Y. (2025). Obesity and the gut microbiota: implications of neuroendocrine and immune signaling. The FEBS Journal. https://doi.org/10.1111/febs.17249

Vancouver

Romaní-Pérez M, Líebana-García R, Flor-Duro A, Bonillo-Jiménez D, Bullich-Vilarrubias C, Olivares M, et al. Obesity and the gut microbiota: implications of neuroendocrine and immune signaling. The FEBS Journal. 2025. doi:10.1111/febs.17249

BibTeX
@article{RomanPrez2025,
  author = {Romaní-Pérez, Marina and Líebana-García, Rebeca and Flor-Duro, Alejandra and Bonillo-Jiménez, Daniel and Bullich-Vilarrubias, Clara and Olivares, Marta and Sanz, Yolanda},
  title = {Obesity and the gut microbiota: implications of neuroendocrine and immune signaling},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.17249}
}
Start for free →